(Q43027405)

12 November 2017

Clinical importance of an elevated circulating chemerin level in incident dialysis patients (English)

1 reference

12 November 2017

0 references

2

1 reference

12 November 2017

7

1 reference

12 November 2017

6

Bengt Lindholm

1 reference

12 November 2017

4

Olof Heimbürger

1 reference

12 November 2017

5

Peter Bárány

1 reference

12 November 2017

3

Björn Anderstam

1 reference

12 November 2017

1

Tae Yamamoto

1 reference

12 November 2017

Jonas Axelsson

8

1 reference

PubMed ID

20543210

12 November 2017

language of work or name

English

0 references

publication date

13 June 2010

1 reference

Nephrology Dialysis Transplantation

12 November 2017

1 reference

12 November 2017

25

1 reference

12 November 2017

12

1 reference

12 November 2017

4017-4023

1 reference

Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.

12 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

The link between abdominal obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Serum levels of the adipokine chemerin in relation to renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Association between serum lipids and survival in hemodialysis patients and impact of race

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

PET imaging of leptin biodistribution and metabolism in rodents and primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ329

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ329

1 reference

12 November 2017

1 reference

PubMed ID

20543210